Diabetes Care Quick Quiz

Yes or No

Played 0

Create copy

About this activity

True or false: diabetes facts.

Created by

Sherif Mohamed Fawzy Abdel-Hamid

Egypt

Download the paper version to play

Top 10 results

There are still no results for this game. Be the first to stay in the ranking! Log in to identify yourself.

Make your own free game from our game creator

Compete against your friends to see who gets the best score in this game

Make challenge

Is it created with Artificial Intelligence? - Complete game

Educaplay Educational Resources

Spain

(17)

Images, songs... Nothing is what it seems anymore. Are they generated with AI, or are they real?
Foot and Ankle Anatomy Quiz

Thilaxshi Suresh

United Kingdom

(9)

Test your knowledge of the bones, joints, and muscles of the foot and ankle with this interactive quiz. Answer with ✅ if the statement is correct and ❌ if it is incorrect.
Grammys for best song/record

Educaplay Educational Resources

Spain

(50)

Answer if these songs won the Grammy for Best Song or Record of the Year (the general ones, category Grammys do not count)
Adjective Checker

Erika Moreno

Ecuador

(14)

In this game, you will have to determine if the adjective provided accurately describes the noun. Test your knowledge of adjectives and see if you can spot the correct matches!
Is it true?

Educaplay Educational Resources

Spain

(59)

Answer if the following sentences about general culture are true or not.


Diabetes Care Quick QuizOnline version True or false: diabetes facts. by Sherif Mohamed Fawzy Abdel-Hamid 1 GLP-1 receptor agonists always cause weight gain. Yes No 2 Type 1 diabetes results from the pancreas' failure to produce enough insulin. Yes No 3 Lantidra is a small molecule drug that lowers blood glucose by stimulating insulin release. Yes No 4 Semaglutide (Ozempic) is approved only for diabetes, not for weight management. Yes No 5 Tirzepatide is a GLP-1 and GIP receptor dual agonist approved in May 2022. Yes No 6 SGLT-2 inhibitors reduce blood glucose independent of insulin action. Yes No 7 Type 2 diabetes begins with insulin resistance. Yes No 8 DPP-4 inhibitors cause significant weight loss. Yes No 9 Gestational diabetes is caused by genetic defects in the pancreas. Yes No 10 Acarbose is an α-glucosidase inhibitor that delays carbohydrate digestion. Yes No

Diabetes Care Quick QuizOnline version

True or false: diabetes facts.

by Sherif Mohamed Fawzy Abdel-Hamid

GLP-1 receptor agonists always cause weight gain.

Yes

Type 1 diabetes results from the pancreas' failure to produce enough insulin.

Yes

Lantidra is a small molecule drug that lowers blood glucose by stimulating insulin release.

Yes

Semaglutide (Ozempic) is approved only for diabetes, not for weight management.

Yes

Tirzepatide is a GLP-1 and GIP receptor dual agonist approved in May 2022.

Yes

SGLT-2 inhibitors reduce blood glucose independent of insulin action.

Yes

Type 2 diabetes begins with insulin resistance.

Yes

DPP-4 inhibitors cause significant weight loss.

Yes

Gestational diabetes is caused by genetic defects in the pancreas.

Yes

Acarbose is an α-glucosidase inhibitor that delays carbohydrate digestion.

Yes

You can integrate the game into an LMS compatible with LTI 1.1 or LTI 1.3 such as Canvas, Moodle, or Blackboard. This way, the scores will be automatically saved into the platform’s gradebook.

Diabetes Care Quick Quiz

Yes or No

About this activity

Created by

Download the paper version to play

Top Games

Yes or No

Is it created with Artificial Intelligence? - Complete game

Yes or No

Foot and Ankle Anatomy Quiz

Yes or No

Grammys for best song/record

Yes or No

Adjective Checker

Yes or No

Is it true?

Diabetes Care Quick QuizOnline version

by Sherif Mohamed Fawzy Abdel-Hamid

GLP-1 receptor agonists always cause weight gain.

Type 1 diabetes results from the pancreas' failure to produce enough insulin.

Lantidra is a small molecule drug that lowers blood glucose by stimulating insulin release.

Semaglutide (Ozempic) is approved only for diabetes, not for weight management.

Tirzepatide is a GLP-1 and GIP receptor dual agonist approved in May 2022.

SGLT-2 inhibitors reduce blood glucose independent of insulin action.

Type 2 diabetes begins with insulin resistance.

DPP-4 inhibitors cause significant weight loss.

Gestational diabetes is caused by genetic defects in the pancreas.

Acarbose is an α-glucosidase inhibitor that delays carbohydrate digestion.

		%
	Anonymous	%
		%
		%